ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

37,655Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 79

$2.44M Total Retail Price of All Prescriptions

Rank: 1 out of 79

693 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

28% of this provider’s 693 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 27,311 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

54 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LISINOPRIL 1,469 973 1 2
SIMVASTATIN 1,294 937 2 3
LEVOTHYROXINE SODIUM 1,153 966 3 1
DONEPEZIL HCL 1,142 998 4 8
FUROSEMIDE 1,104 824 5 4
HYDROCODONE-ACETAMINOPHEN 1,023 658 S3 6 5
TRAZODONE HCL 1,017 658 7 19
NAMENDA 925 870 8 9
AMLODIPINE BESYLATE 908 662 9 6
WARFARIN SODIUM 769 585 10 14
METOPROLOL TARTRATE 747 583 11 10
CARVEDILOL 713 512 12 21
MIRTAZAPINE 627 525 13 15
CITALOPRAM HBR 623 419 14 18
POTASSIUM CHLORIDE 579 392 15 11
QUETIAPINE FUMARATE 564 371 16 20
NOVOLIN R 562 352 17 39
METFORMIN HCL 540 333 18 13
RISPERIDONE 537 327 19 24
SERTRALINE HCL 448 317 20 16
LEVETIRACETAM 432 277 21 43
ESCITALOPRAM OXALATE 429 343 22 25
CYMBALTA 421 270 23 27
RANITIDINE HCL 409 297 24 33
GABAPENTIN 405 218 25 12
HYDROCHLOROTHIAZIDE 393 321 26 22
OMEPRAZOLE 387 305 27 7
RAMIPRIL 359 312 28 47
DIVALPROEX SODIUM 318 183 29 29
LANTUS 313 186 30 26
GLIPIZIDE 306 216 31 61
HYDRALAZINE HCL 294 198 32 67
TRAMADOL HCL 283 215 33 17
BENZTROPINE MESYLATE 279 110 R 34 72
BACLOFEN 266 108 35 84
ATORVASTATIN CALCIUM 263 148 36 30
SEROQUEL 262 181 37 51
METOPROLOL SUCCINATE 261 170 38 23
CLONIDINE HCL 240 167 39 49
CLOPIDOGREL 234 190 40 31
LACTULOSE 221 163 41 40
DIVALPROEX SODIUM ER 218 115 42 85
ZOLPIDEM TARTRATE 212 131 43 28
ALENDRONATE SODIUM 205 205 44 32
ABILIFY 205 102 44 74
TRAVATAN Z 201 172 46 100
PLAVIX 198 163 47 46
TAMSULOSIN HCL 189 143 48 36
CARBIDOPA-LEVODOPA 186 149 49 44
NOVOLIN 70-30 186 122 49 82
ALBUTEROL SULFATE 183 153 51 50
POLYETHYLENE GLYCOL 3350 170 150 52 58
TRANSDERM-SCOP 169 121 10 53 156
PROMETHAZINE HCL 169 132 R 53 76
HALOPERIDOL 168 114 55 106
DIGOXIN 166 141 56 42
VALPROIC ACID 162 87 57 117
LEXAPRO 158 132 58 90
OLANZAPINE 154 137 59 57
KLOR-CON M10 148 135 60 68
MEGESTROL ACETATE 144 134 R 61 146
LEVOFLOXACIN 139 113 62 68
FAMOTIDINE 134 100 63 60
PHENYTOIN SODIUM EXTENDED 132 87 64 96
BUSPIRONE HCL 130 94 65 135
NOVOLOG 128 81 66 66
NIFEDIPINE ER 126 101 67 113
ISOSORBIDE MONONITRATE ER 125 100 68 59
SULFAMETHOXAZOLE-TRIMETHOPRIM 123 80 69 81
EXELON 119 119 70 41
OXYBUTYNIN CHLORIDE 119 88 70 129
NEXIUM 119 96 70 34
ATENOLOL 115 106 73 45
DIOVAN 115 96 73 56
SPIRONOLACTONE 112 81 75 64
LATANOPROST 112 102 75 88
PANTOPRAZOLE SODIUM 110 65 77 37
RENVELA 108 42 78 173
KLOR-CON M20 108 83 78 63
SANTYL 106 95 80 92
GLUCAGEN 105 55 81 148
PHENYTOIN 104 95 82 128
HUMULIN R 102 86 83 129
SPIRIVA 101 66 84 94
ADVAIR DISKUS 98 74 85 70
MUPIROCIN 98 74 85 98
JANUVIA 97 38 87 89
ISOSORBIDE DINITRATE 96 73 88 160
LIDODERM 95 89 89 55
LYRICA 92 80 90 73
PATANOL 91 81 91 151
PRAVASTATIN SODIUM 89 61 92 38
PREDNISONE 89 74 92 54
BRIMONIDINE TARTRATE 81 76 94 154
TRICOR 80 58 95 140
GLYBURIDE 79 59 R 96 78
VERAPAMIL ER 79 67 96 122
LOSARTAN POTASSIUM 78 41 98 35
CIPROFLOXACIN HCL 77 65 99 79
TIMOLOL MALEATE 74 68 100 228
ALLOPURINOL 73 68 101 65
IPRATROPIUM-ALBUTEROL 73 60 101 71
DOXAZOSIN MESYLATE 72 45 103 104
FLUTICASONE PROPIONATE 71 56 104 47
AGGRENOX 68 68 105 147
CARBAMAZEPINE 68 39 105 190
OXYBUTYNIN CHLORIDE ER 66 42 107 110
NITROFURANTOIN MONO-MACRO 66 56 107 115
METHIMAZOLE 66 66 107 236
DETROL LA 65 65 110 137
SINGULAIR 65 55 110 108
COMBIGAN 64 61 112 241
AMIODARONE HCL 62 48 113 123
CRESTOR 62 49 113 62
FENOFIBRATE 60 47 115 119
NYSTATIN 60 49 115 80
ISOSORBIDE MONONITRATE 59 55 117 177
VENLAFAXINE HCL ER 59 57 117 126
ZIPRASIDONE HCL 58 39 119 157
ROPINIROLE HCL 56 37 120 109
RISPERDAL CONSTA 56 14 120 256
NITROGLYCERIN PATCH 56 56 120 114
BUPROPION HCL 56 54 120 170
CEPHALEXIN 55 40 124 121
ZETIA 54 30 125 138
AMOXICILLIN 51 36 126 213
TRIAMCINOLONE ACETONIDE 51 32 126 157
LOXAPINE 51 17 126 272
DILTIAZEM HCL 51 41 126 136
GENERLAC 51 36 126 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.